Active Ingredients
Menthol 4.50%
Uriflex Fast Acting Analgesic Pain Relief Cream
FDA Label NDC 73168-004
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Rejuvica Llc for the product Uriflex Fast Acting Analgesic Pain Relief (NDC 73168-004). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients, purposes, uses:, warnings:, do not apply, keep out of reach of children., if pregnant or breast feeding,, directions:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Purposes
External Analgesic
Uses:
For temporary relief of minor aches and pains associated with simple backache, arthritis, bruises, sprains, and strains.
Warnings:
For External Use Only. Avoid Contact With Eyes.
Do Not Apply
to Open Wounds or Damaged Skin. If symptoms persist for more than seven days, discontinue use and consult physician.
Keep Out Of Reach Of Children.
If swallowed, consult physician. Do not bandage tightly.
If Pregnant Or Breast Feeding,
contact physician prior to use.
Directions:
Apply directly to affected area. Do not use more than four times per day.
Other Ingredients:
Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Aloe Barbadensis Leaf (Aloe Vera Gel) Juice, Aqua (Deionized Water), Cetyl Alcohol, Diazolidinyl Urea, Isopropyl Myristate, Methyl Paraben, Methyl Salicylate, PEG-8, Propyl Paraber, Propylene Glycol, Sodium Laruyl Sulfate, Triethanolamine.
Package Labeling:
Label (Label)
* Please review the disclaimer below.
